Log in
The 12-Panel Urine Drug Test Dip Card uses lateral flow chromatographic immunoassay technology to detect specific drugs and their metabolites in human urine.
During testing, the absorbent end of the dip card is immersed into the urine specimen. The specimen moves through the individual test strips, where specific antibodies react with the targeted drugs or metabolites.
If the concentration of a drug is below the established screening cutoff, both the Control (C) and Test (T) lines appear, indicating a negative result.
If the concentration of a drug is equal to or greater than the established cutoff level, the Test (T) line does not appear while the Control (C) line remains visible, indicating a preliminary positive result.
Because this device provides preliminary screening results only, any preliminary positive result should be confirmed using GC-MS or LC-MS/MS before medical, legal, or employment decisions are made.
Amphetamine is a prescription central nervous system (CNS) stimulant used medically to treat conditions such as ADHD and narcolepsy. It increases activity in the brain and nervous system, which can improve alertness, concentration, and energy.
Amphetamine also has a potential for misuse and dependence because of its stimulating effects. For this reason, it is commonly included in professional urine drug screening panels.
Increased energy
Heightened alertness
Improved concentration
Elevated mood
Increased heart rate
Reduced appetite
Restlessness
Anxiety
Difficulty sleeping
Long-term misuse may contribute to dependence, cardiovascular problems, behavioral changes, and other health complications.
Speed, Uppers, Bennies, Pep Pills, Dexies, Addys.
Amphetamine is generally detectable in urine for approximately 1–3 days after use, although detection time may vary depending on dosage, frequency of use, metabolism, and other individual factors.
Barbiturates are central nervous system depressants that have been used medically to treat certain seizure disorders and other conditions. They can produce sedative and calming effects but carry a risk of misuse, dependence, and overdose.
Relaxation
Drowsiness
Sedation
Slowed breathing
Poor coordination
Slurred speech
Dizziness
Confusion
Long-term misuse can result in physical dependence, respiratory depression, and potentially life-threatening overdose.
Barbs, Downers, Reds, Blues, Yellow Jackets.
Barbiturates may be detectable in urine for approximately 2–15 days, depending on the specific medication and individual factors.
Benzodiazepines are prescription medications commonly used to treat anxiety, panic disorders, insomnia, muscle spasms, and certain seizure conditions. They work by reducing activity in the central nervous system and producing calming and sedative effects.
Relaxation
Reduced anxiety
Drowsiness
Muscle relaxation
Slowed reflexes
Memory impairment
Poor coordination
Dizziness
Misuse or prolonged use may result in tolerance, dependence, and withdrawal symptoms.
Benzos, Xannies, Bars, Vallies, Tranks, Downers.
Benzodiazepines are generally detectable in urine for approximately 2–7 days, although some long-acting medications may remain detectable for longer.
Buprenorphine is a prescription medication commonly used in the treatment of opioid use disorder. It is a partial opioid agonist that can help reduce opioid cravings and withdrawal symptoms.
Although it is used therapeutically, buprenorphine can also be misused and is therefore included in certain professional drug screening programs.
Reduced opioid cravings
Reduced withdrawal symptoms
Pain relief
Relaxation
Drowsiness
Dizziness
Nausea
Headache
Misuse may lead to dependence and other opioid-related complications.
Bupe, Subs, Bupes.
Buprenorphine may generally be detectable in urine for approximately 2–4 days, although detection time can vary according to dosage, frequency of use, and individual metabolism.
Cocaine is a powerful central nervous system stimulant derived from the coca plant. It produces short-lasting stimulating effects and has a high potential for misuse and addiction.
Increased energy
Euphoria
Heightened alertness
Rapid heartbeat
Elevated blood pressure
Reduced appetite
Anxiety
Restlessness
Long-term misuse may contribute to cardiovascular complications, stroke, depression, and substance dependence.
Coke, Blow, Snow, Crack, Rock, Flake, Yayo, White, Dust.
Cocaine metabolites are generally detectable in urine for approximately 2–4 days after use.
Methamphetamine is a powerful synthetic central nervous system stimulant that can produce intense stimulation, increased energy, and heightened alertness. It has a high potential for misuse and dependence.
Intense euphoria
Increased energy
Heightened alertness
Rapid heartbeat
Elevated blood pressure
Reduced appetite
Anxiety
Restlessness
Long-term misuse may contribute to severe weight loss, paranoia, hallucinations, memory problems, and other serious complications.
Meth, Crystal Meth, Crystal, Ice, Glass, Tina.
Methamphetamine is generally detectable in urine for approximately 2–4 days after use.
MDMA (3,4-Methylenedioxymethamphetamine) is a synthetic psychoactive substance with stimulant and hallucinogenic properties. It affects several neurotransmitters in the brain and may produce feelings of euphoria, increased energy, and emotional warmth.
Euphoria
Increased energy
Emotional warmth
Increased sensory perception
Increased heart rate
Jaw clenching
Sweating
Dehydration
Repeated or high-dose use may contribute to anxiety, depression, sleep problems, and other health complications.
Ecstasy, Molly, X, E, Beans, Adam, Rolls.
MDMA is generally detectable in urine for approximately 2–4 days after use.
Methadone is a long-acting synthetic opioid prescribed for pain management and opioid use disorder treatment. It can reduce
opioid withdrawal symptoms and cravings when used as part of a supervised treatment program.
Pain relief
Reduced opioid cravings
Relaxation
Drowsiness
Slowed breathing
Sweating
Dizziness
Nausea
Improper use can result in dependence, respiratory depression, overdose, and other serious complications.
Fizzies, Juice, Amidone, Methadose.
Methadone is generally detectable in urine for approximately 3–7 days after use.
Opiates are naturally occurring opioid substances derived from the opium poppy, including morphine and codeine. They are used medically for pain relief but can also produce euphoric and sedative effects.
Pain relief
Euphoria
Relaxation
Drowsiness
Constricted pupils
Slowed breathing
Nausea
Constipation
Misuse may lead to tolerance, dependence, respiratory depression, overdose, and other serious complications.
Smack, Dope, H, Horse, Junk, Mud, Big O.
Opiates are generally detectable in urine for approximately 2–3 days, depending on the specific substance and frequency of use.
Oxycodone is a prescription opioid medication used to treat moderate to severe pain. It works by binding to opioid receptors in the central nervous system to reduce the perception of pain.
Because oxycodone can cause tolerance, dependence, and respiratory depression, it is commonly included in professional drug screening programs.
Pain relief
Relaxation
Euphoria
Drowsiness
Reduced alertness
Nausea
Constipation
Slowed breathing
Misuse can result in dependence, respiratory depression, overdose, and other serious complications.
Oxy, OxyContin, OC, Hillbilly Heroin, Percs.
Oxycodone is generally detectable in urine for approximately 1–3 days after use.
Phencyclidine (PCP) is a dissociative substance that can significantly alter perception, mood, behavior, and coordination. It was originally developed as an anesthetic but is no longer used medically because of its adverse psychological effects.
Hallucinations
Detachment from reality
Confusion
Agitation
Loss of coordination
Numbness
Elevated blood pressure
Altered perception
Heavy or prolonged use may result in severe psychological and neurological complications.
Angel Dust, Sherm, Wet, Rocket Fuel, Love Boat.
PCP is generally detectable in urine for approximately 5–8 days, although chronic use may result in a longer detection period.
Marijuana is a psychoactive substance derived from the Cannabis sativa plant. Its primary psychoactive component is delta-9-tetrahydrocannabinol (THC), which affects cannabinoid receptors in the brain.
Relaxation
Euphoria
Altered perception
Increased appetite
Dry mouth
Red eyes
Slowed reaction time
Impaired coordination
Frequent or heavy use may contribute to memory problems, reduced concentration, anxiety, and cannabis dependence.
Weed, Pot, Cannabis, Grass, Herb, Ganja, Mary Jane, Hash.
THC may be detectable in urine for approximately 3–30 days, depending on frequency and amount of use. Chronic users may remain positive for several weeks.
The 12-Panel Urine Drug Test Dip Card provides a fast, convenient, and comprehensive solution for preliminary urine drug screening. Designed to simultaneously detect 12 commonly monitored substances, it combines a simple dip-and-read procedure with rapid lateral flow immunoassay technology to provide preliminary qualitative results in approximately 5 minutes.
With screening coverage for Amphetamine, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine, Methamphetamine, MDMA, Methadone, Morphine/Opiates, Oxycodone, Phencyclidine, and Marijuana, this dip card is suitable for a wide range of professional drug screening applications.
The convenient format makes it practical for workplace testing, occupational health programs, healthcare facilities, rehabilitation centers, clinical settings, correctional facilities, and forensic applications.
As with all preliminary immunoassay drug screening tests, any preliminary positive result should be confirmed using an appropriate laboratory confirmation method such as GC-MS or LC-MS/MS before making medical, legal, or employment-related decisions.
The 12-Panel Urine Drug Test Dip Card is a rapid, one-step urine drug screening device designed to provide fast, convenient, and reliable preliminary detection of 12 commonly monitored drugs in human urine. Using lateral flow chromatographic immunoassay technology, the dip card provides preliminary qualitative results in approximately 5 minutes, making it suitable for professional drug screening environments.
The simple dip-and-read format allows trained personnel to perform multiple drug tests simultaneously using a single urine specimen. Its straightforward design helps reduce complicated testing steps while providing clear and easy-to-interpret results.
This 12-panel configuration screens for Amphetamine (AMP), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Cocaine (COC), Methamphetamine (MET), MDMA (Ecstasy), Methadone (MTD), Morphine/Opiates (MOP), Oxycodone (OXY), Phencyclidine (PCP), and Marijuana (THC).
The test is suitable for workplace drug testing, occupational health programs, healthcare facilities, rehabilitation centers, physician offices, correctional facilities, forensic testing, and substance abuse monitoring programs.
This assay provides preliminary qualitative screening results only. Any preliminary positive result should be confirmed using a more specific analytical technique such as Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) before medical, legal, or employment decisions are made.
This 12-panel configuration screens for:
Drug
Typical Detection Window
Amphetamine (AMP)
1–3 Days
Barbiturates (BAR)
2–15 Days
Benzodiazepines (BZO)
2–7 Days*
Buprenorphine (BUP)
2–4 Days
Cocaine (COC)
2–4 Days
Methamphetamine (MET)
2–4 Days
MDMA (Ecstasy)
2–4 Days
Methadone (MTD)
3–7 Days
Opiates (MOP)
2–3 Days
Oxycodone (OXY)
1–3 Days
Phencyclidine (PCP)
5–8 Days
Marijuana (THC)
3–30 Days
*Long-acting benzodiazepines may remain detectable for several weeks.
A colored line appears in both the Control (C) region and the Test (T) region for the corresponding drug panel. Even a faint Test (T) line should be interpreted as a negative result.
Only one colored line appears in the Control (C) region while no line appears in the corresponding Test (T) region. This indicates that the drug concentration may be at or above the established screening cutoff level.
A preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS) or Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS) before medical, legal, or employment decisions are made.
If no colored line appears in the Control (C) region, the test is invalid regardless of whether a Test (T) line appears. Repeat the test using a new test device and a fresh urine specimen.
iScreen™ 12 Panel Urine Test Dip Card | Abbott | Amphetamine, Barbiturates, Benzodiazepines, Buprenorphine, Cocaine, Methamphetamine, MDMA (Ecstasy), Methadone, Morphine/Opiates, Oxycodone, Phencyclidine, Marijuana | DOA-1124-081 25/Box
Sign up for updates from leading retailers
